EPIGENETIC REGULATION OF ROR1 IN CHRONIC LYMPHOCYTIC LEUKEMIA DEFINES PREFERABLE TARGET FOR COMBINED EPIGENETIC AND IMMUNE THERAPY

被引：0
|
作者：
Skorka, K. [1 ]
Karp, M. [1 ]
Zakrzewska, E. [1 ]
Zaleska, J. [1 ]
Zajac, M. [1 ]
Karczmarczyk, A. [1 ]
Purkot, J. [1 ]
Tomczak, W. [2 ]
Wlasiuk, P. [1 ]
Matosiuk, D. [3 ]
Giannopoulos, K. [1 ,4 ]
机构：
[1] Med Univ Lublin, Dept Expt Hematooncol, Lublin, Poland
[2] Med Univ Lublin, Dept Hematooncol & Bone Marrow Transplantat, Lublin, Poland
[3] Med Univ Lublin, Dept Synth & Technol Pharmaceut Subst, Lublin, Poland
[4] St Johns Canc Ctr, Dept Hematooncol 3, Lublin, Poland
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P584
引用
收藏
页码：224 / 224
页数：1
相关论文
共 50 条
  • [21] Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia
    Hojjat-Farsangi, Mohammad
    Jeddi-Tehrani, Mahmood
    Daneshmanesh, Amir Hossein
    Mozaffari, Fariba
    Moshfegh, Ali
    Hansson, Lotta
    Razavi, Seyed Mohsen
    Sharifian, Ramazan Ali
    Rabbani, Hodjattallah
    Osterborg, Anders
    Mellstedt, Hakan
    Shokri, Fazel
    PLOS ONE, 2015, 10 (11):
  • [22] Combined ROR1 and CD160 Detection For Improved Minimal Residual Disease In Patients With Chronic Lymphocytic Leukemia (CLL)
    Farren, Timothy W.
    Liu, Fengting
    Macey, Marion G.
    Kipps, Thomas J.
    Warner, Noel
    Agrawal, Samir G.
    BLOOD, 2013, 122 (21)
  • [23] Immune therapy for chronic lymphocytic leukemia induces the antibody response against a novel tumor-associated antigen, the orphan tyrosine kinase receptor ROR1
    Fukuda, T
    Rassenti, LZ
    Kipps, TJ
    BLOOD, 2005, 106 (11) : 834A - 835A
  • [24] Does CD5 have an effect on the expression of ROR1 in chronic lymphocytic leukemia (CLL)?
    Alsulami, H.
    Hallek, M.
    Kreuzer, K. A.
    ONKOLOGIE, 2011, 34 : 138 - 139
  • [25] SMALL MOLECULES TARGETING ROR1 INDUCE SPECIFIC KILLING OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) CELLS
    Moshfegh, A.
    Khan, S.
    Vagberg, J.
    Bystrom, S.
    Hojat-Farsangi, M.
    Mansouri, L.
    Sandin, A.
    Manesh, A. Danesh
    Osterborg, A.
    Mellstedt, H.
    HAEMATOLOGICA, 2012, 97 : 433 - 433
  • [26] Efficient Gene Delivery to Chronic Lymphocytic Leukemia (CLL) Cells with Microbubbles Bearing ROR1 Antibody
    Zhang, Suping
    Cui, Wenjin
    Mattrey, Robert
    Kipps, Thomas J.
    BLOOD, 2011, 118 (21) : 1232 - 1232
  • [27] A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact
    Queiros, A. C.
    Villamor, N.
    Clot, G.
    Martinez-Trillos, A.
    Kulis, M.
    Navarro, A.
    Penas, E. M. M.
    Jayne, S.
    Majid, A.
    Richter, J.
    Bergmann, A. K.
    Kolarova, J.
    Royo, C.
    Russinol, N.
    Castellano, G.
    Pinyol, M.
    Bea, S.
    Salaverria, I.
    Lopez-Guerra, M.
    Colomer, D.
    Aymerich, M.
    Rozman, M.
    Delgado, J.
    Gine, E.
    Gonzalez-Diaz, M.
    Puente, X. S.
    Siebert, R.
    Dyer, M. J. S.
    Lopez-Otin, C.
    Rozman, C.
    Campo, E.
    Lopez-Guillermo, A.
    Martin-Subero, J. I.
    LEUKEMIA, 2015, 29 (03) : 598 - 605
  • [28] A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact
    A C Queirós
    N Villamor
    G Clot
    A Martinez-Trillos
    M Kulis
    A Navarro
    E M M Penas
    S Jayne
    A Majid
    J Richter
    A K Bergmann
    J Kolarova
    C Royo
    N Russiñol
    G Castellano
    M Pinyol
    S Bea
    I Salaverria
    M López-Guerra
    D Colomer
    M Aymerich
    M Rozman
    J Delgado
    E Giné
    M González-Díaz
    X S Puente
    R Siebert
    M J S Dyer
    C López-Otín
    C Rozman
    E Campo
    A López-Guillermo
    J I Martín-Subero
    Leukemia, 2015, 29 : 598 - 605
  • [29] Tumor Antigen ROR1 targeted delivery of MiR-29b in chronic lymphocytic leukemia induces epigenetic reprograming resulting in cell cycle arrest and therapeutic benefit in-vivo
    Chiang, Chi-Ling
    Goswami, Swagata
    Frissora, Frank
    Xie, Zhiliang
    Huang, Xiaomeng
    Mani, Rajeswaran
    Baskar, Sivasubramanian
    Rader, Christoph
    Phelps, Mitch
    Marcucci, Guido
    Byrd, John C.
    Lee, L. James
    Muthusamy, Natarajan
    LEUKEMIA & LYMPHOMA, 2017, 58 : 79 - 80
  • [30] High-Level Expression of ROR1 Associates with Early Disease Progression in Patients with Chronic Lymphocytic Leukemia
    Cui, Bing
    Chen, Liguang
    Rassenti, Laura Z.
    Ghia, Emanuela M.
    Yu, Jian
    Zhang, Ling
    Neuberg, Donna S.
    Wierda, William
    Keating, Michael
    Rai, Kanti R.
    Kay, Neil E.
    Brown, Jennifer R.
    Byrd, John C.
    Gribben, John
    Kipps, Thomas J.
    BLOOD, 2015, 126 (23)
12345